Research Articles
The Hidden Switches: How mTOR-Associated lncRNAs Are Revolutionizing Breast Cancer Treatment
Discover how mTOR-associated long non-coding RNAs are transforming breast cancer diagnosis and treatment through cutting-edge research.
The Hidden Switch: How a Tiny Genetic Change Can Increase Breast Cancer Risk
Discover how a single genetic letter change in a p53 control switch can weaken cellular defenses and increase breast cancer risk.
The Hidden Link: How a Forgotten Gene Is Reshaping Our Fight Against Breast Cancer
Groundbreaking research on the NF1 gene reveals why some breast cancers resist treatment and opens new avenues for combatting the disease.
The Erythropoietin Gene Mystery: Why a Promising Cancer Link Didn't Pan Out
Exploring the functional polymorphism of erythropoietin gene rs1617640 and its lack of association with early-stage breast cancer.
The Amino Acid Transporter SLC7A5: A New Bullseye for Targeting Aggressive Breast Cancer
Comprehensive analysis of SLC7A5 amino acid transporter's role in aggressive breast cancer subtypes and its potential as therapeutic target
The CB2 Puzzle: Unlocking Cannabinoid Receptor 2's Role in Breast Cancer
Exploring the paradoxical role of CB2 receptor in breast cancer progression and the feasibility of its knockdown for therapeutic applications.
The Genetic Spellchecker: How a Tiny DNA Change Might Influence Breast Cancer Risk
Exploring how the XRCC1 Arg399Gln polymorphism affects breast cancer risk across different populations and its interaction with environmental factors.
The CEP55-HSF1 Tango: How a Tiny Protein Fuels Breast Cancer's Deadly Defenses
Unveiling the molecular dance behind chemotherapy resistance in aneuploid breast cancer through CEP55-HSF1 interaction
The ABCC3 Gene: How a Molecular "Sump Pump" Drives Taxane Resistance in HER2+ Breast Cancer
Discover how ABCC3 gene amplification drives taxane resistance in HER2+ breast cancer and the latest research on overcoming this challenge.
The MANCR Code: How a Tiny Cellular Conductor Fuels Aggressive Breast Cancer
Discover how the lncRNA MANCR drives genomic instability in triple-negative breast cancer and its potential as a therapeutic target.